about
Secondary Structure of the 3' Terminus of Hepatitis C Virus Minus-Strand RNAThe crystal structure of HIV reverse-transcription primer tRNA(Lys,3) shows a canonical anticodon loopThe Life-Cycle of the HIV-1 Gag-RNA Complex8-Modified-2'-deoxyadenosine analogues induce delayed polymerization arrest during HIV-1 reverse transcriptionHIV-1 polymerase inhibition by nucleoside analogs: cellular- and kinetic parameters of efficacy, susceptibility and resistance selectionLabeling of multiple HIV-1 proteins with the biarsenical-tetracysteine systemInfluenza NA and PB1 Gene Segments Interact during the Formation of Viral Progeny: Localization of the Binding Region within the PB1 Gene.Dimerization of HIV-1 genomic RNA of subtypes A and B: RNA loop structure and magnesium bindingStructural and functional properties of the HIV-1 RNA-tRNA(Lys)3 primer complex annealed by the nucleocapsid protein: comparison with the heat-annealed complexInteraction network linking the human H3N2 influenza A virus genomic RNA segments.An in vitro network of intermolecular interactions between viral RNA segments of an avian H5N2 influenza A virus: comparison with a human H3N2 virus.Two step synthesis of (-) strong-stop DNA by avian and murine reverse transcriptases in vitro.Mutational analysis of the tRNA3Lys/HIV-1 RNA (primer/template) complex.Structural basis of genomic RNA (gRNA) dimerization and packaging determinants of mouse mammary tumor virus (MMTV).Evaluation of anti-HIV-1 mutagenic nucleoside analogues.RNA loop-loop interactions as dynamic functional motifs.HIV-1 replication and the cellular eukaryotic translation apparatusSelective packaging of the influenza A genome and consequences for genetic reassortment.Dimerization of retroviral RNA genomes: an inseparable pair.A supramolecular assembly formed by influenza A virus genomic RNA segmentsHIV controls the selective packaging of genomic, spliced viral and cellular RNAs into virions through different mechanisms.MIMEAnTo: profiling functional RNA in mutational interference mapping experiments.Nucleoside and nucleotide inhibitors of HIV-1 replication.A structure-based approach for targeting the HIV-1 genomic RNA dimerization initiation site.Advances in the structural understanding of Vif proteinsCritical role of segment-specific packaging signals in genetic reassortment of influenza A virusesA functional sequence-specific interaction between influenza A virus genomic RNA segmentsSHAPE analysis of the 5' end of the Mason-Pfizer monkey virus (MPMV) genomic RNA reveals structural elements required for genome dimerization.Tumultuous relationship between the human immunodeficiency virus type 1 viral infectivity factor (Vif) and the human APOBEC-3G and APOBEC-3F restriction factors.Translational regulation of APOBEC3G mRNA by Vif requires its 5'UTR and contributes to restoring HIV-1 infectivity.Initiation of HIV-1 reverse transcription and functional role of nucleocapsid-mediated tRNA/viral genome interactions.The role of Vif oligomerization and RNA chaperone activity in HIV-1 replication.RNA and DNA binding properties of HIV-1 Vif protein: a fluorescence study.Solution studies of the dimerization initiation site of HIV-1 genomic RNA.In vitro characterization of naturally occurring influenza H3NA- viruses lacking the NA gene segment: toward a new mechanism of viral resistance?5-Modified-2'-dU and 2'-dC as mutagenic anti HIV-1 proliferation agents: synthesis and activity.HIV-1 Pr55Gag binds genomic and spliced RNAs with different affinity and stoichiometry.First snapshots of the HIV-1 RNA structure in infected cells and in virions.Mutational interference mapping experiment (MIME) for studying RNA structure and function.Inhibition of human immunodeficiency virus type 1 reverse transcriptase, RNase H, and integrase activities by hydroxytropolones.
P50
Q27473515-C061CC9D-C4BF-40D9-BF6B-24E11E0C9FFAQ27628091-DC48553E-B8BB-4205-9325-4592BC346BB8Q28076985-0ECC71D7-8138-407C-A30B-7FAB5A873567Q28477840-32A2AE8F-4B5C-49A3-9AEE-783E35052FA4Q28478993-1987751B-CF95-4BAA-90A9-EF53119B3EA1Q28742843-CB49261C-BB85-49C3-B69E-FAB997839E7AQ30392174-E6F7D71E-6803-4BAD-8CC6-126894A0F869Q34362112-3071828D-07BD-4BFC-9997-F23DF070A15DQ34364188-F8F9193C-E800-4B6C-B973-27F2FF75711EQ34444938-CC869EE2-CD06-4ABB-896B-6E27DD3D9800Q34503923-A798EF6D-4FBB-43E0-B654-831D97530F7EQ34625646-6851118A-11F7-4AB3-94BD-6D325599574FQ34658242-447CE5D3-FA0B-4E60-B973-1DB4FEAF182FQ34686549-E7C842EF-BC13-4709-849A-D317A3B7CD5CQ34801497-02FC8824-1431-4563-B2CE-9A6CAD5A7D6CQ35012331-B5A28B1A-A94D-49C4-8827-F5F41AEA3257Q35014929-5016E9FC-E739-45E1-BF13-8E7754B0C94DQ35163445-FF7D6EB3-D06B-4BD6-9CFE-6E369AE9CAC4Q35777663-976A3251-B965-4666-A4BB-60A2FA49FD40Q35823770-C776E5AD-A6C2-4076-8D47-BF9A49B34ACDQ35829334-725E8023-8959-4CE1-B396-D36E3B8E6914Q36073573-CD95308B-E472-4993-A758-F1880ED47F3DQ36359017-91CE867A-49D0-4A38-BA3B-1C4F75F3E115Q36792049-086C8A61-F5EC-4A85-AD22-6168C62CF044Q37108363-7F01F3D1-D4EC-4B50-A498-C792362FE47DQ37218430-17F8CC47-F2BE-4FCD-A06A-9CF57DC41B5DQ37236521-324F0F36-BC91-4DEB-9684-A71B0A4BB6F5Q37448705-C484789D-4F7A-4060-9401-3E60AF68D93CQ37504507-B0B40D2F-A5C9-45F3-8A5B-CE6A6E49D58DQ37518508-73A3F475-723B-4878-857E-DF54294371F4Q38020621-53A6DAB2-8499-40E7-9D4A-0957B8FF9619Q38021305-857024F6-7E09-4865-B8BC-9B337AE0A649Q38300337-5D1CDE53-F9FC-40B8-B9CA-E6E65DE36D39Q38335346-A67694CA-B87B-403B-9F8D-534441BF9830Q39680790-8627CB5B-6720-4226-96CC-FD4F3F9F86D5Q39746338-D5BDD9BB-53F8-487D-BF09-361A837F6498Q40476785-6081B6F5-84E5-46F7-B762-BD577412F5F5Q40517865-90A25174-B4DE-4B1B-8F9D-646AB085A8FCQ40666101-1BB18F34-AEA0-4A70-A743-94F44146B3B9Q40666856-7BFD5D4C-6468-41AB-BE8E-0B64583E9543
P50
description
French
@en
wetenschapper
@nl
name
Roland Marquet
@ast
Roland Marquet
@en
Roland Marquet
@es
Roland Marquet
@nl
Roland Marquet
@sl
type
label
Roland Marquet
@ast
Roland Marquet
@en
Roland Marquet
@es
Roland Marquet
@nl
Roland Marquet
@sl
prefLabel
Roland Marquet
@ast
Roland Marquet
@en
Roland Marquet
@es
Roland Marquet
@nl
Roland Marquet
@sl
P214
P106
P1153
7102123218
P21
P214
P31
P496
0000-0002-4209-3976
P734
P735
P7859
viaf-211850154